You are viewing 1 post for April 2010
Direct-To-Consumer Advertising of Prescription Drugs
Volume 15, Issue 3
In 2007, the pharmaceutical industry spent more than $4.9 billion on direct-to-consumer advertising (DTCA) of prescription drugs in the U.S. Controversy over DTCA has grown since the Food and Drug Administration liberalized its regulations in 1997. Proponents claim that such advertising educates consumers, promotes patient participation in…
